Etomoxir, the experimental medication that inhibits CPT1A and has been tested as a preventative for congestive heart failure, may be used to treat chemo-resistant ovarian cancer.
from Medindia Health News https://ift.tt/2UpQMkh
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
March 27, 2020
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.